Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Xie Q, Bu W, Bhatia S, Hare J, Somasundaram T, Azzi A, Chapman MS.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10405-10. Epub 2002 Jul 22.

2.

The role of the adeno-associated virus capsid in gene transfer.

Van Vliet KM, Blouin V, Brument N, Agbandje-McKenna M, Snyder RO.

Methods Mol Biol. 2008;437:51-91. doi: 10.1007/978-1-59745-210-6_2. Review.

PMID:
18369962
3.

Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations.

Selot RS, Hareendran S, Jayandharan GR.

Curr Pharm Biotechnol. 2014;14(12):1072-82. Review.

PMID:
24678652
4.

Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them.

Hareendran S, Balakrishnan B, Sen D, Kumar S, Srivastava A, Jayandharan GR.

Rev Med Virol. 2013 Nov;23(6):399-413. doi: 10.1002/rmv.1762. Epub 2013 Sep 10. Review.

PMID:
24023004
5.
6.

Adeno-associated virus: fit to serve.

Zinn E, Vandenberghe LH.

Curr Opin Virol. 2014 Oct;8:90-7. doi: 10.1016/j.coviro.2014.07.008. Epub 2014 Aug 13. Review.

7.

Immune responses to AAV in clinical trials.

Mingozzi F, High KA.

Curr Gene Ther. 2011 Aug;11(4):321-30. Review.

PMID:
21557723
8.

Immune responses to AAV in clinical trials.

Mingozzi F, High KA.

Curr Gene Ther. 2007 Oct;7(5):316-24. Review.

PMID:
17979678
9.

Immune responses to adeno-associated virus vectors.

Zaiss AK, Muruve DA.

Curr Gene Ther. 2005 Jun;5(3):323-31. Review.

PMID:
15975009

Supplemental Content

Support Center